Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs LaSara Medical Group

By GLP-1 ScorecardUpdated

Enhance MD
Site position #14

Higher score

LaSara Medical GroupFactor scores not reassessed.
Site position #486

Lower score

Score comparison

Enhance MD has the higher recorded score — 84.8/100 to 54.5/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.

Before you choose

Before comparing the headline prices, the Enhance MD review and the LaSara Medical Group review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Enhance MD vs Levers Health and Freya Meds vs LaSara Medical Group compare each of them with another graded program, and the list of alternatives to Enhance MD ranks the programs closest to Enhance MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEnhance MD +49
82
33
Dose & formulationEnhance MD +18
82
64
Clinical oversightEnhance MD +19
88
69
Labs & monitoringEnhance MD +37
90
53
FulfillmentEnhance MD +18
84
66
Contract termsEnhance MD +37
84
47
Enhance MD · top barLaSara Medical Group · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEnhance MDLaSara Medical Group
WeighScore84.8/10054.5/100
GradeBC
Site position#14#486
Semaglutide$249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$289/mo (compounded)
Tirzepatide$329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$399/mo (bundle, compounded)
CoverageFAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your addressCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Enhance MD

Site position #14 · B

Strengths

  • Core and Advanced publish separate short- and longer-plan prices with billing periods stated
  • Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
  • Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
  • The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy

What to consider

  • Four-week billing and a 48-week longer plan are not twelve calendar-month payments
  • First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
  • An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
  • Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
  • One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
  • Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
LaSara Medical Group

Site position #486 · C

Factor scores not reassessed.

Strengths

  • Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
  • National telehealth plus an in-person option in Southern California — uncommon hybrid model
  • Free initial consultation
  • Active promotional pricing (30% off sitewide at the time of review)
  • GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles

What to consider

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • LegitScript certification status not confirmed
  • Per-state availability not listed despite the national-telehealth claim
  • Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard